Biomaterial-associated infections account for over one million nosocomial infections per year, and their prevention is a critical component to successful regenerative medicine strategies. Bacterial infection of biomaterial implants frequently results in complete removal of the implant despite aggressive antibiotic therapy. Staphylococcus aureus and Pseudomonas aeruginosa are the most clinically relevant gram positive and gram negative pathogens associated with medical device failure. Bacteriophages are bacteria-specific viruses that have the ability to infect and lyse host bacteria. We have recently engineered a poly (ethylene glycol) (PEG)-based hydrogel system for controlled delivery of therapeutic proteins that facilitates bone repair in a murine radial segmental defect model. Contamination of these hydrogels with bacteria leads to complete inhibition of bone healing, persistence of bacteria, and bone resorption. The objective of this project is to engineer PEG- based hydrogels that are infection resistant. The central hypothesis is that delivery of bacteriophage using a PEG-hydrogel will reduce infection in a mouse model for bone repair.
Aim 1 : Engineer hydrogels for controlled delivery of active bacteriophage to eliminate bacteria.
Aim 2 : Examine the ability of phage presenting hydrogels to reduce infection and improve bone repair.
Aim 3 : Characterize the in vivo inflammatory response to bacteriophage containing hydrogels. The proposed research is innovative because it focuses on developing biomaterials that resistant infection without the use of antibiotics, thereby reducing the development of antibiotic resistant bacteria while minimizing implanted device failure. As outcomes of this research, we will establish the feasibility of controlled bacteriophage release hydrogels to reduce infection and promote bone repair. This research will establish a strategy for infection-resistant biomaterials that is applicable to various biomedical devices.

Public Health Relevance

Biomaterials play an important role in assisting in the bone healing process. When these materials are infected with bacteria, they are no longer capable of aiding in the bone regenerative process and need to be surgically removed. We will engineer implants to be resistant to bacterial infection by incorporating bacteria specific viruses called bacteriophages.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Individual Predoctoral NRSA for M.D./Ph.D. Fellowships (ADAMHA) (F30)
Project #
5F30AR069472-05
Application #
9649181
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Washabaugh, Charles H
Project Start
2016-02-22
Project End
2020-02-23
Budget Start
2019-02-24
Budget End
2020-02-23
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Emory University
Department
Biomedical Engineering
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Bhutani, Srishti; Nachlas, Aline L Y; Brown, Milton E et al. (2018) Evaluation of Hydrogels Presenting Extracellular Matrix-Derived Adhesion Peptides and Encapsulating Cardiac Progenitor Cells for Cardiac Repair. ACS Biomater Sci Eng 4:200-210
Headen, Devon M; Woodward, Kyle B; Coronel, MarĂ­a M et al. (2018) Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance. Nat Mater 17:732-739
Jang, Yeongseon; Choi, Won Tae; Johnson, Christopher T et al. (2018) Inhibition of Bacterial Adhesion on Nanotextured Stainless Steel 316L by Electrochemical Etching. ACS Biomater Sci Eng 4:90-97
Johnson, Christopher T; Wroe, James A; Agarwal, Rachit et al. (2018) Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing. Proc Natl Acad Sci U S A 115:E4960-E4969
Weaver, Jessica D; Headen, Devon M; Aquart, Jahizreal et al. (2017) Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites. Sci Adv 3:e1700184